ONO-2808

DRUG3 trials

Sponsors

Ono Pharmaceutical Co. Ltd, Ono Pharmaceutical Co., Ltd.

Conditions

Multiple System Atrophy (MSA)Multiple System Atrophy, Parkinson VariantNeurodegenerative Diseases

Phase 1

A First in Human Study to Assess the Safety, Tolerability and Pharmacokinetics of ONO-2808-01 in Healthy Participants

CompletedNCT04578028

Ono Pharmaceutical Co. LtdNeurodegenerative Diseases

Start: 2020-08-19End: 2021-10-07Updated: 2021-12-30

Phase 2

A Phase 2 Study of ONO-2808 in Patients With Multiple System Atrophy

Active, not recruitingNCT05923866

Ono Pharmaceutical Co., Ltd.Multiple System Atrophy (MSA)

Start: 2023-09-22End: 2027-10-31Updated: 2026-06-29

Phase 3

A Trial of ONO-2808 in Participants With the Parkinsonian Subtype of Multiple System Atrophy (MSA-P)

Not yet recruitingNCT07825402

Ono Pharmaceutical Co., Ltd.Multiple System Atrophy, Parkinson Variant

Start: 2027-01-01End: 2029-10-01Target: 486Updated: 2026-09-17